Compare Humana Inc (HUM) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Xcel Energy Inc — how do they compare? Humana Inc trades at $398.55 (market cap $47.81B), while Xcel Energy Inc trades at $78.7 (market cap $49.11B). The key difference: Humana Inc and Xcel Energy Inc are close in size by market cap, and Xcel Energy Inc pays the higher dividend (3.01%). Which is the better fit depends on your goals.
| HUM | XEL | |
|---|---|---|
Market Cap | $47.81B | $49.11B |
Sector | Health | Utilities |
52-Week High | $409.42 | $83.91 |
52-Week Low | $163.67 | $71.14 |
Enterprise Value | $56.85B | $86.55B |
Dividend Yield | 0.89% | 3.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Xcel Energy (XEL) trades at $78.71, down 0.08% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed quarterly earnings, beating Q1 2026 estimates but missing Q3 and Q4 2025. Revenue grew to $14.67 billion in 2025, with a net income margin of 14.14%. Recent news highlights a $60 billion capital plan through 2030 to support electrical demand growth from data centers and industrial expansion.
XEL presents a stable utility investment with a 62.96% analyst buy rating and a consensus price target of $93.86, implying 19% upside. Key opportunities include EPS growth projected at 9.6% annually through 2028, but risks involve regulatory pushback on rate increases and high debt levels with a debt-to-asset ratio of 41.64% in 2025. The stock's valuation at a P/E of 22.7 is reasonable for its growth outlook.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
